1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Piccart, M
  • Hortobagyi, GN
  • Campone, M
  • Pritchard, Kathleen
  • Noguchi, S
  • Rugo, H
  • Gnant, M
  • Feng, W
  • Taran, T
  • Baselga, J

publication date

  • March 2014